dual CTLA-4 checkpoint inhibitor/CD40 costimulator (Alligator Bioscience)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namedual CTLA-4 checkpoint inhibitor/CD40 costimulator (Alligator Bioscience)
Drug Alias NameMitazalimab (ADC-1013)-Derived Bispecific CTLA-4 Checkpoint Inhibitor/CD40 Costimulator Antibody (Alligator Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitorsTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5Cytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlligator Bioscience Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlligator Bioscience Ab
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A